Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Teva Pharmaceutical Industries has agreed to sell assets and operations of Actavis Generics in the UK and Ireland to Accord Healthcare Limited (a subsidiary of Intas Pharmaceuticals Ltd) for an agreed value of GBP 603 million, subject to final ...
read more
Friday, December 15, 2017
Teva Pharmaceutical announced a restructuring plan to significantly reduce its cost base, which includes laying off 14,000 employees worldwide.
read more
Wednesday, October 02, 2019
Teva Pharmaceutical announced the retirement of Dr. Carlo de Notaristefani, and the appointment of Eric Drapé as Executive Vice President, Global Operations.
read more
HitGen announced the company has entered into a research collaboration with Almirall to identify novel small molecule leads for targets of interest.
read more
Teva Pharmaceutical announced the launch of a generic version of Ranexa® (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S.
read more
Friday, December 15, 2017
Teva Pharmaceutical announced the exclusive launch of generic Viread tablets 300 mg in the U.S.
read more
Wednesday, August 07, 2019
Teva announced Michael McClellan, Executive Vice President and Chief Financial Officer (CFO), has decided to step down from his role as CFO due to personal reasons.
read more
Thursday, November 20, 2025
TetraScience announced that Bayer AG will expand its deployment of TetraScience's Scientific Data Foundry across its pharmaceutical and crop science R&D operations.
read more
Wednesday, December 18, 2019
Tetra Bio-Pharma announced the signing of a definitive agreement with Azevedos Indústria Farmacêutica for the marketing and distribution of CAUMZTM in Portugal.
read more
Monday, December 02, 2019
Tetra Bio-Pharma has signed a definitive co-development and commercialization agreement with Alternavida for the clinical development, marketing and distribution of CAUMZTM in Mexico.
read more
Tetra has awarded the contract for the manufacturing of its API, HU-308, and of the intravenous, sterile, finished drug product ARDS-003 to Dalton.
read more
Friday, December 01, 2017
TesoRx and ASKA have expanded their existing collaboration to develop and commercialize TesoRx's novel oral testosterone product, TSX-011.
read more
Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and ...
read more
Tergus Pharma, the leading topical Contract Development and Manufacturing Organization (CDMO), officially opened its new, 100,000 sq. ft. headquarters and commercial manufacturing facility with a ribbon-cutting ceremony on May 13, 2021.
read more
Tergus Pharma has announced the hiring of Heather N. Sugrue as VP of Business Development.
read more